The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 4,666 | 38,135 | SH | SOLE | 38,135 | 0 | 0 | ||
| IMPERVA INC | COM | 45321L100 | 2,178 | 56,716 | SH | SOLE | 56,716 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 7,117 | 65,500 | SH | SOLE | 65,500 | 0 | 0 | ||
| NXP SEMICONDUCTORS N V | COM | N6596X109 | 25,483 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
| RITE AID CORP | COM | 767754104 | 13,497 | 1,638,000 | SH | SOLE | 1,638,000 | 0 | 0 | ||
| WGL HLDGS INC | COM | 92924F106 | 11,442 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||